Leap Therapeutics, Inc. (LPTX) Ownership

NASDAQ Currency in USD Disclaimer

$2.89

north_east $0.11 (3.96%)
Day's range
$2.75
Day's range
$3

Leap Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 05/15/2023 7.43 M $2.52 M   1,226.69% 5.74%
PERCEPTIVE ADVISORS LLC 05/16/2023 6.73 M $2.29 M   0.00% 5.20%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2023 4.66 M $1.58 M   27.20% 3.60%
ARTAL GROUP S.A. 05/12/2023 4.00 M $1.36 M   0.00% 3.09%
VANGUARD GROUP INC 07/14/2023 3.21 M $1.09 M   0.00% 2.48%
683 CAPITAL MANAGEMENT, LLC 05/15/2023 2.80 M $952,000   1.82% 2.16%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2023 2.01 M $684,141   151.52% 1.56%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2023 1.54 M $523,000   100.00% 1.19%
KEY CLIENT FIDUCIARY ADVISORS, LLC 04/25/2023 1.54 M $522,177   13.82% 1.19%
CORMORANT ASSET MANAGEMENT, LP 05/15/2023 1.48 M $504,000   100.00% 1.15%
UBS OCONNOR LLC 05/15/2023 1.05 M $356,553   100.00% 0.81%
CITADEL ADVISORS LLC 05/15/2023 1.05 M $341,499   142.64% 0.81%
SAMSARA BIOCAPITAL, LLC 08/14/2023 846,038 $287,653   100.00% 0.65%
BLACKROCK INC. 05/12/2023 619,013 $210,464   0.91% 0.48%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2023 618,673 $210,348   0.00% 0.48%
KNOTT DAVID M JR 05/11/2023 557,939 $190,000   -33.58% 0.43%
RENAISSANCE TECHNOLOGIES LLC 05/12/2023 455,200 $155,000   -50.83% 0.35%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2023 453,441 $155,000   100.00% 0.35%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2023 298,301 $101,422   0.00% 0.23%
PLATINUM INVESTMENT MANAGEMENT LTD 05/12/2023 264,413 $89,900   -80.09% 0.20%
ADVISOR GROUP HOLDINGS, INC. 05/12/2023 183,895 $62,524   1.08% 0.14%
STATE STREET CORP 05/15/2023 177,739 $60,431   0.00% 0.14%
NORTHERN TRUST CORP 05/15/2023 152,931 $51,997   20.84% 0.12%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2023 50,700 $17,238   -4.52% 0.04%
MCADAM, LLC 04/24/2023 45,778 $15,565   39.64% 0.04%
ANNANDALE CAPITAL, LLC 05/15/2023 40,000 $14,000   0.00% 0.03%
TWO SIGMA INVESTMENTS, LP 05/15/2023 39,790 $13,529   -59.43% 0.03%
BANK OF NEW YORK MELLON CORP 05/09/2023 35,483 $12,064   0.00% 0.03%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/12/2023 32,000 $10,880   0.00% 0.02%
RAYMOND JAMES & ASSOCIATES 04/14/2023 29,678 $10,091   -11.88% 0.02%
TWO SIGMA ADVISERS, LP 05/15/2023 27,400 $9,316   -90.73% 0.02%
LPL FINANCIAL LLC 05/10/2023 26,375 $8,968   -4.52% 0.02%
JANNEY MONTGOMERY SCOTT LLC 04/28/2023 25,000 $8,000   0.00% 0.02%
CITADEL ADVISORS LLC 05/15/2023 21,500 $7,310   -8.51% 0.02%
GROUP ONE TRADING, L.P. 05/12/2023 21,240 $7,222   -18.75% 0.02%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 05/16/2023 17,000 $5,000   100.00% 0.01%
CNB BANK 05/10/2023 16,000 $5,440   0.00% 0.01%
VALEO FINANCIAL ADVISORS, LLC 04/17/2023 15,635 $5,316   0.00% 0.01%
BAYSTATE WEALTH MANAGEMENT LLC 04/25/2023 15,385 $5,231   0.00% 0.01%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/16/2023 14,973 $5,091   -50.61% 0.01%
COMMUNITY TRUST & INVESTMENT CO 04/18/2023 13,650 $4,641   0.00% 0.01%
UBS GROUP AG 05/12/2023 13,064 $4,442   30.64% 0.01%
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. 04/14/2023 12,878 $4,379   100.00% 0.01%
MILLENNIUM MANAGEMENT LLC 05/15/2023 12,670 $4,000   -98.85% 0.01%
D.A. DAVIDSON & CO. 04/25/2023 11,000 $3,740   100.00% 0.01%
MORGAN STANLEY 05/15/2023 10,334 $3,514   4.17% 0.01%
JANE STREET GROUP, LLC 05/16/2023 10,008 $3,403   -94.48% 0.01%
DONALDSON CAPITAL MANAGEMENT, LLC 04/13/2023 10,000 $3,400   0.00% 0.01%
CAPTRUST FINANCIAL ADVISORS 05/15/2023 10,000 $3,400   100.00% 0.01%
US BANCORP \DE\ 05/09/2023 6,100 $2,074   0.00% 0.00%

Leap Therapeutics, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of LPTX shares?

During the previous two years, 2 institutional investors and hedge funds held shares of Leap Therapeutics, Inc.. The most heavily invested institutionals were:

HealthCor Management, L.P.: 0

ACT CAPITAL MANAGEMENT, LLC: 265,000

What percentage of Leap Therapeutics, Inc. stock is owned by institutional investors?

33.00% of Leap Therapeutics, Inc. stock is owned by institutional investors.

How much institutional buying is happening at LPTX ?

Institutional investors have bought a total of 265,000 shares in the last 24 months. This purchase volume represents approximately $765,850 in transactions.